Raiffeisen Bank International’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7K Buy
+105
New +$19.3K ﹤0.01% 642
2025
Q3
Sell
-822
Closed -$111K 827
2025
Q2
$105K Sell
822
-749
-48% -$93.3K ﹤0.01% 472
2025
Q1
$217K Hold
1,571
﹤0.01% 430
2024
Q4
$236K Buy
+1,571
New +$265K ﹤0.01% 425

Other funds holding BIIB

Raiffeisen Bank International's BIIB Position: Q1 2026 in Review

Raiffeisen Bank International opened a new position in Biogen (BIIB) in Q1 2026: 105 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Raiffeisen Bank International previously reported a position in BIIB as recently as Q2 2025.

Raiffeisen Bank International first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. The position peaked at $236K in Q4 2024. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Raiffeisen Bank International held 105 shares of Biogen worth $19.7K as of Q1 2026.
  • Biogen was a new Raiffeisen Bank International position in Q1 2026.
  • Biogen made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #642 holding.
  • Raiffeisen Bank International first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • Raiffeisen Bank International's Biogen position peaked at $236K in Q4 2024.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.